BMS/Pfizer's Eliquis better than Lovenox, but comparison with Pradaxa and Xarelto not clear, says NICE
25 November 2011
Francesca Bruce
Please Login to read the full article.
25 November 2011
Francesca Bruce
Please Login to read the full article.
RELATED CONTENT
NEWS
- BMS' Eliquis: NICE fast-track yes for VTE but its no better than Xarelto or Pradaxa
- Bayer's Xarelto to join Pradaxa for NICE stroke prevention
- ADOPT data not major setback for Eliquis from BMS/Pfizer
- Bayer must convince NICE it has not overestimated the effectiveness of Xarelto
ANALYSIS
Other Informa Analysis
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
